Reply to the Letter to the Editor on "Third generation aromatase inhibitors may prevent endometrial growth and reverse tamoxifen-induced uterine changes in postmenopausal breast cancer patients", by I. Cohen Ann Oncol 2005; 16: 1399

Ann Oncol. 2005 Aug;16(8):1402-3; author reply 1402-3. doi: 10.1093/annonc/mdi237. Epub 2005 May 3.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents, Hormonal / adverse effects*
  • Aromatase Inhibitors / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Endometrium / drug effects*
  • Endometrium / growth & development
  • Endometrium / pathology
  • Female
  • Humans
  • Postmenopause
  • Tamoxifen / adverse effects*
  • Uterine Diseases / chemically induced*
  • Uterine Diseases / prevention & control*

Substances

  • Antineoplastic Agents, Hormonal
  • Aromatase Inhibitors
  • Tamoxifen